PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
17-Jan-2023 Ovarian cancer: Innovative research approach identifies target proteins for potential anti-tumor drug rhenium tricarbonyl (TRIP). IMC Krems – University of Applied Sciences
17-Jan-2023 SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial SolasCure
17-Jan-2023 Enalees appoints Eric Germain as managing director Andrew Lloyd Associates
17-Jan-2023 Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next-Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality Avectas
17-Jan-2023 ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002 ImmunOs Therapeutics
17-Jan-2023 Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer Pan Cancer T
17-Jan-2023 GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma GPCR Therapeutics
17-Jan-2023 Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project Andrew Lloyd Associates
16-Jan-2023 EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer   Andrew Lloyd Associates
16-Jan-2023 CD Formulation Offers 16 types of Food Ingredients as Raw Materials to Manufacture Health Care Products CD Formulation
12-Jan-2023 Novotech Acquires US-based Drug Development Consulting Firm, CBR International Novotech Health Holdings Pte Ltd
12-Jan-2023 Novotech Acquires European CRO, Strengthens Global Operations Novotech Health Holdings Pte Ltd
11-Jan-2023 Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future Samsung Biologics
11-Jan-2023 Keranova’s FemtoMatrix technology produces unprecedented results in clinical regulatory trials  Andrew Lloyd Associates
10-Jan-2023 Kayentis and ClinOne join forces to improve efficiency and patient experience in clinical trials Andrew Lloyd Associates
10-Jan-2023 STORM Therapeutics Expands R&D Leadership Team STORM Therapeutics
10-Jan-2023 Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark Phastar
10-Jan-2023 Lynred launches HEROIC, €18M European Defence Fund project to produce strategic electronics for next-generation infrared sensors Andrew Lloyd Associates
10-Jan-2023 Viralgen receives cGMP certification to produce rAAV commercial grade product at new facility in San Sebastian, Spain Viralgen
10-Jan-2023 ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank ExeVir Bio